Differential Diagnostics Market Size, Share, Trends &Forecast 2028

Summary

Report Description

Global Differential Diagnostics Market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. This can be ascribed to the increasing prevalence of various types of diseases such as influenza, COVID diseases, cardiac diseases, and infectious diseases across the globe. Also, the growing accessibility of point-of-care testing products through online platforms will drive the growth of the market in the forecast period. Similarly, growing healthcare decentralization and high investments and funding for project development are expected to enhance the growth of the differential diagnostic market in the coming years. Availability of affordable diagnostic tests for chronic illness in the developing region is anticipated to propel the growth of the market. In January 2022, the Therapeutic Goods Administration (TGA) granted provisional approval for Novavax's COVID-19 vaccine branded as Nuvaxovid for use in Australia.

Rising the Diagnostic Tests

Due to the growing number of diagnostic tests, people are demanding the best diagnostic test which will easily detect diseases and is anticipated to boost the growth of the market during the forecasted period. Diagnostic tests are performed in a private or public laboratory with appropriate equipment and sometimes expensive instrumentation and staffed with trained and qualified personnel. Growing demand for point-of-care testing which occurs at the nearest site of patient care is sought in the field of infectious bacterial diagnostics to allow the care team to receive more results quickly and make immediate and informed management decisions. For molecular diagnosis, different types of diseases can be detected by using differential diagnosis which is challenging. Governments and different organizations are investing for research and development purposes in the healthcare sector which is a major factor in driving the growth of the differential diagnostics market during the forecasted period. In 2021, according to the National Aids Control Organization (NACO), approximately 2.40 million people in India were infected with HIV. Of the total HIV-infected population 45% were women and 2% were below 12. Also, a growing number of clinics will enhance the demand for differential diagnostic tests market over the years. According to the Non-communicable Diseases Key Facts published by the World Health Organization (WHO) in April 2021, chronic diseases kill around 41 million people each year, which is equivalent to 71% of all deaths worldwide.

Download Free Sample Report

Growing Technological Advancements

Growing advancements in diagnostic technology helped physicians to evaluate processes and events in real-time. The clinical application of advances in physics and mathematics resulted in the development of diagnostic tools. These developments help physicians to get more accurate, less invasive, and less expensive which will boost the market growth during the forecasted years. Also, the growing demand for diagnostic kits for at-home usage has resulted in technical developments which are expected to create significant growth in the forecast period. Leica Microsystems, a Danaher subsidiary, declared the debut of STELLARIS, the company's flagship platform for its revolutionary confocal microscope, in April 2020. This platform allows the viewing of live tissues and cells in three dimensions.

Market Segmentation

Global Differential Diagnostics Market is segmented into treatment type, usability, end use, and by region. Based on treatment type, the market can be segmented into Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, and Sleep Problems. Based on Usability, the market can be segmented into Systems, Kits, Assays, Reagents, and Consumables. Based on end use, the market can be differentiated into Hospitals, Diagnostic Centers, and Others. Regionally, North America dominate the market among Asia Pacific, Europe, Middle East & Africa, and South America. In terms of country, the United States region is dominating the overall globe in differential diagnostics market. According to CDC in 2020, 79,611,982 people have tested for COVID-19 in the United States. This can be ascribed to the increasing cost-effective covid-19 testing technology in the healthcare sector.

Recent Development

In January 2021, Roche introduced its Cobas Pulse System in a few nations that accepted the CE Mark. The item is a networked point-of-care solution from Roche Diagnostics' most recent generation. The most recent release provides expert blood glucose management.
In September 2021, Ortho Clinical Diagnostics announced that Immediate Spin Crossmatch (ISXM), a tool for identifying recipient and donor incompatibility in blood transfusions, will be made available on the company's Ortho Vision and Ortho Vision Max Analyzers.

Market Players

Thermo Fisher Scientific Inc., Hologic, Inc., Quidel Corporation., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Inc, Danaher Corporation, Meridian Bioscience Inc., GenMark Diagnostics, Inc., Sekisui Diagnostics Co., Ltd., Luminex Corporation. are some of the leading players operating in the Global Differential Diagnostics Market.

Attribute	Details
Base Year	2022
Historic Data	2018 – 2021
Estimated Year	2023
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million, Volume in Units, and CAGR for 2018-2022 and 2023-2028
Report Coverage	Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends
Segments Covered	By Treatment Type By Usability By End User By Region
Regional scope	North America; Europe; Asia Pacific; South America; Middle East & Africa
Country scope	United States; Mexico; Canada; France; Germany; United Kingdom; Italy; Spain; China; India; South Korea; Japan; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Egypt; Turkey
Key companies profiled	Thermo Fisher Scientific Inc., Hologic, Inc., Quidel Corporation., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Inc, Danaher Corporation, Meridian Bioscience Inc., GenMark Diagnostics, Inc., Sekisui Diagnostics Co., Ltd., Luminex Corporation.
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, Global Differential Diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Differential Diagnostics Market, By Treatment Type:

o Chest Pain

o Headache

o Fever

o Pneumonia

o Hypertension

o Fatigue

o Sleep Problems

Differential Diagnostics Market, By Usability:

o Physical Health Disorders

o Mental Health Disorders

· Differential Diagnostics Market, By End Use:

o Hospitals

o Diagnostic Centers

o Others

· Differential Diagnostics Market, By Region:

o North America

§ United States

§ Mexico

§ Canada

o Europe

§ France

§ Germany

§ United Kingdom

§ Italy

§ Spain

o Asia Pacific

§ China

§ India

§ South Korea

§ Japan

§ Australia

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

§ Egypt

§ Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Differential Diagnostics Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Differential Diagnostics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Differential Diagnostics Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)

5.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)

5.2.3. By End Use (Hospitals, Diagnostic Centers, Others)

5.2.4. By Region

5.2.5. By Company (2022)

5.3. Product Map

5.3.1. By Treatment Type

5.3.2. By Usability

5.3.3. By End Use

5.3.4. By Region

6. North America Differential Diagnostics Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)

6.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)

6.2.3. By End Use (Hospitals, Diagnostic Centers, Others)

6.2.4. By Country

6.3. North America: Country Analysis

6.3.1. United States Differential Diagnostics Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Treatment Type

6.3.1.2.2. By Usability

6.3.1.2.3. By End Use

6.3.2. Canada Differential Diagnostics Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Treatment Type

6.3.2.2.2. By Usability

6.3.2.2.3. By End Use

6.3.3. Mexico Differential Diagnostics Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Treatment Type

6.3.3.2.2. By Usability

6.3.3.2.3. By End Use

7. Europe Differential Diagnostics Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)

7.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)

7.2.3. By End Use (Hospitals, Diagnostic Centers, Others)

7.2.4. By Country

7.3. Europe: Country Analysis

7.3.1. France Differential Diagnostics Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Treatment Type

7.3.1.2.2. By Usability

7.3.1.2.3. By End Use

7.3.2. Germany Differential Diagnostics Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Treatment Type

7.3.2.2.2. By Usability

7.3.2.2.3. By End Use

7.3.3. United Kingdom Differential Diagnostics Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Treatment Type

7.3.3.2.2. By Usability

7.3.3.2.3. By End Use

7.3.4. Italy Differential Diagnostics Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Treatment Type

7.3.4.2.2. By Usability

7.3.4.2.3. By End Use

7.3.5. Spain Differential Diagnostics Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Treatment Type

7.3.5.2.2. By Usability

7.3.5.2.3. By End Use

8. Asia-Pacific Differential Diagnostics Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)

8.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)

8.2.3. By End Use (Hospitals, Diagnostic Centers, Others)

8.2.4. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Differential Diagnostics Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Treatment Type

8.3.1.2.2. By Usability

8.3.1.2.3. By End Use

8.3.2. India Differential Diagnostics Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Treatment Type

8.3.2.2.2. By Usability

8.3.2.2.3. By End Use

8.3.3. Japan Differential Diagnostics Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Treatment Type

8.3.3.2.2. By Usability

8.3.3.2.3. By End Use

8.3.4. South Korea Differential Diagnostics Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Treatment Type

8.3.4.2.2. By Usability

8.3.4.2.3. By End Use

8.3.5. Australia Differential Diagnostics Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Treatment Type

8.3.5.2.2. By Usability

8.3.5.2.3. By End Use

9. South America Differential Diagnostics Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)

9.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)

9.2.3. By End Use (Hospitals, Diagnostic Centers, Others)

9.2.4. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Differential Diagnostics Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Treatment Type

9.3.1.2.2. By Usability

9.3.1.2.3. By End Use

9.3.2. Argentina Differential Diagnostics Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Treatment Type

9.3.2.2.2. By Usability

9.3.2.2.3. By End Use

9.3.3. Colombia Differential Diagnostics Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Treatment Type

9.3.3.2.2. By Usability

9.3.3.2.3. By End Use

10. Middle East and Africa Differential Diagnostics Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems)

10.2.2. By Usability (Physical Health Disorders, Mental Health Disorders)

10.2.3. By End Use (Hospitals, Diagnostic Centers, Others)

10.2.4. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Differential Diagnostics Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Treatment Type

10.3.1.2.2. By Usability

10.3.1.2.3. By End Use

10.3.2. Saudi Arabia Differential Diagnostics Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Treatment Type

10.3.2.2.2. By Usability

10.3.2.2.3. By End Use

10.3.3. UAE Differential Diagnostics Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Treatment Type

10.3.3.2.2. By Usability

10.3.3.2.3. By End Use

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

13. Global Differential Diagnostics Market: SWOT Analysis

14. Porter’s Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Business Overview

15.2. Product Offerings

15.3. Recent Developments

15.4. Financials (As Reported)

15.5. Key Personnel

15.6. SWOT Analysis

15.6.1. Thermo Fisher Scientific Inc.

15.6.2. Hologic, Inc.

15.6.3. Quidel Corporation.

15.6.4. F. Hoffmann-La Roche Ltd.

15.6.5. Abbott Laboratories, Inc.

15.6.6. Danaher Corporation

15.6.7. Meridian Bioscience Inc.

15.6.8. GenMark Diagnostics, Inc.

15.6.9. Sekisui Diagnostics Co., Ltd.

15.6.10. Luminex Corporation.

16. Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the Global Differential Diagnostics Market?

The rise in the prevalence of infectious diseases, increase in awareness for point-of-care testing, and advancements in the techniques are the major drivers for the Global Differential Diagnostics Market.

Who are the top players operating in the Differential Diagnostics Market?

Thermo Fisher Scientific Inc., Hologic, Inc., Quidel Corporation., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Inc., Danaher Corporation., Meridian Bioscience Inc., GenMark Diagnostics, Inc., Sekisui Diagnostics Co., Ltd., Luminex Corporation, among others are some of the leading players operating in the Global Differential Diagnostics Market.